Evidence map›Paper›PMID 38531855›Full record

ArticleNature communications2024

Synthetically-primed adaptation of Pseudomonas putida to a non-native substrate D-xylose.

Pavel Dvořák, Barbora Burýšková, Barbora Popelářová, Birgitta E Ebert, Tibor Botka, Dalimil Bujdoš, Alberto Sánchez-Pascuala, Hannah Schöttler, Heiko Hayen, Víctor de Lorenzo and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Multi-layered metabolic remodeling ofMetabolic engineering communications · 2026
    Article
  6. Article
  7. Engineering mixed sugar metabolic channels inSynthetic and systems biotechnology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Construction of a syntrophicSynthetic biology (Oxford, England) · 2025
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 5 countries.

Pavel Dvořák *Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 753/5, 62500, Brno, Czech Republic. pdvorak@sci.muni.cz.ORCID http://orcid.org/0000-0002-3215-4763
Barbora Burýšková *Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 753/5, 62500, Brno, Czech Republic.ORCID http://orcid.org/0000-0002-9945-1893
Barbora Popelářová *Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 753/5, 62500, Brno, Czech Republic.ORCID http://orcid.org/0000-0003-3760-0539
Birgitta E Ebert *Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Cnr College Rd & Cooper Rd, St Lucia, QLD, QLD 4072, Australia.ORCID http://orcid.org/0000-0001-9425-7509
Tibor BotkaDepartment of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 753/5, 62500, Brno, Czech Republic.ORCID http://orcid.org/0000-0003-2708-3718
Dalimil BujdošAPC Microbiome Ireland, University College Cork, College Rd, Cork, T12 YT20, Ireland.ORCID http://orcid.org/0000-0003-1709-8289
Alberto Sánchez-PascualaDepartment of Biochemistry and Synthetic Metabolism, Max Planck Institute for Terrestrial Microbiology, Karl-von-Frisch-Straße 10, 35043, Marburg, Germany.ORCID http://orcid.org/0000-0003-2359-8626
Hannah SchöttlerInstitute of Inorganic and Analytical Chemistry, University of Münster, Corrensstraße 48, 48149, Münster, Germany.ORCID http://orcid.org/0000-0001-7792-746X
Heiko HayenInstitute of Inorganic and Analytical Chemistry, University of Münster, Corrensstraße 48, 48149, Münster, Germany.ORCID http://orcid.org/0000-0002-4074-8545
Víctor de LorenzoSystems and Synthetic Biology Program, Centro Nacional de Biotecnología CNB-CSIC, Cantoblanco, Darwin 3, 28049, Madrid, Spain.ORCID http://orcid.org/0000-0002-6041-2731
Lars M BlankInstitute of Applied Microbiology, RWTH Aachen University, Worringer Weg 1, 52074, Aachen, Germany.ORCID http://orcid.org/0000-0003-0961-4976
Martin BenešíkDepartment of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 753/5, 62500, Brno, Czech Republic.
Masaryk University · CZUniversity of Münster · DECentro Nacional de Biotecnología · ESMax Planck Institute for Terrestrial Microbiology · DERWTH Aachen University · DEThe University of Queensland · AUUniversity College Cork · IE

Funding

Grantová Agentura České Republiky (Grant Agency of the Czech Republic) 22-12505S
6 · The paper itself

Abstract

To broaden the substrate scope of microbial cell factories towards renewable substrates, rational genetic interventions are often combined with adaptive laboratory evolution (ALE). However, comprehensive studies enabling a holistic understanding of adaptation processes primed by rational metabolic engineering remain scarce. The industrial workhorse Pseudomonas putida was engineered to utilize the non-native sugar D-xylose, but its assimilation into the bacterial biochemical network via the exogenous xylose isomerase pathway remained unresolved. Here, we elucidate the xylose metabolism and establish a foundation for further engineering followed by ALE. First, native glycolysis is derepressed by deleting the local transcriptional regulator gene hexR. We then enhance the pentose phosphate pathway by implanting exogenous transketolase and transaldolase into two lag-shortened strains and allow ALE to finetune the rewired metabolism. Subsequent multilevel analysis and reverse engineering provide detailed insights into the parallel paths of bacterial adaptation to the non-native carbon source, highlighting the enhanced expression of transaldolase and xylose isomerase along with derepressed glycolysis as key events during the process.

Indexed as

Pseudomonas putidaXyloseMetabolic EngineeringPentose Phosphate PathwayTransaldolaseTransaldolaseXylose

Identifiers

PMID38531855
PMCPMC10965963
OpenAlexW4393187460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.